James Quigley
Stock Analyst at Goldman Sachs
(0.21)
# 4,560
Out of 4,707 analysts
335
Total ratings
40.1%
Success rate
-7%
Average return
Main Sectors:
Stocks Rated by James Quigley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NVO Novo Nordisk | Maintained: Hold | $47 → $44 | $46.60 | -5.58% | 10 | Aug 6, 2026 | |
| LON: 0QIU Novo Nordisk A/S | Maintained: Hold | kr 305.00 → kr 285.00 | kr 298.95 | -4.67% | 36 | Aug 6, 2026 | |
| ETR: BAYN Bayer Aktiengesellschaft | Maintained: Buy | €62.50 → €63.50 | €48.71 | +30.36% | 61 | Aug 5, 2026 | |
| ETR: SRT3 Sartorius Aktiengesellschaft | Maintained: Hold | €229.00 → €190.00 | €233.70 | -18.70% | 31 | Jul 24, 2026 | |
| SWX: LONN Lonza Group AG | Maintained: Buy | CHF 670.00 → CHF 680.00 | CHF 560.60 | +21.30% | 22 | Jul 23, 2026 | |
| SWX: NOVN Novartis AG | Maintained: Sell | CHF 111.00 → CHF 113.00 | CHF 125.46 | -9.93% | 27 | Jul 22, 2026 | |
| EPA: SAN Sanofi | Maintained: Hold | €89.00 → €84.00 | €75.69 | +10.98% | 10 | Jul 6, 2026 | |
| SWX: ROP Roche Holding AG | Maintained: Hold | CHF 346.00 → CHF 348.00 | CHF 353.60 | -1.58% | 26 | Jun 30, 2026 | |
| EPA: DIM Sartorius Stedim Biotech S.A. | Maintained: Buy | €214.00 | €186.50 | +14.75% | 23 | Apr 23, 2026 | |
| ETR: MRK Merck KGaA | Maintained: Buy | €153.00 → €147.00 | €135.10 | +8.81% | 43 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $54.97 | - | 1 | Jan 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $121 → $118 | $159.99 | -26.25% | 3 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $832.00 | n/a | 1 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $65 → $60 | $44.24 | n/a | 2 | Jul 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | 15,200p | 12,042p | n/a | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €13.00 → €10.50 | €0.85 | n/a | 2 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €27.00 → €28.00 | €3.21 | n/a | 10 | Sep 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | CHF 65.00 → CHF 64.00 | CHF 76.95 | n/a | 2 | Sep 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 38.00 → CHF 21.00 | CHF 44.00 | n/a | 5 | Sep 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | €38.00 → €36.00 | €24.42 | n/a | 2 | Sep 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $15 | $1.86 | n/a | 5 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €410.00 → €545.00 | €869.40 | n/a | 2 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | kr 1,950 → kr 2,235 | kr 2,165 | n/a | 7 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $140 → $205 | $28.49 | n/a | 2 | Jan 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $33.60 | n/a | 1 | Jun 20, 2018 |
Novo Nordisk
Aug 6, 2026
Maintained: Hold
Price Target: $47 → $44
Current: $46.60
Upside: -5.58%
Novo Nordisk A/S
Aug 6, 2026
Maintained: Hold
Price Target: kr 305.00 → kr 285.00
Current: kr 298.95
Upside: -4.67%
Bayer Aktiengesellschaft
Aug 5, 2026
Maintained: Buy
Price Target: €62.50 → €63.50
Current: €48.71
Upside: +30.36%
Sartorius Aktiengesellschaft
Jul 24, 2026
Maintained: Hold
Price Target: €229.00 → €190.00
Current: €233.70
Upside: -18.70%
Lonza Group AG
Jul 23, 2026
Maintained: Buy
Price Target: CHF 670.00 → CHF 680.00
Current: CHF 560.60
Upside: +21.30%
Novartis AG
Jul 22, 2026
Maintained: Sell
Price Target: CHF 111.00 → CHF 113.00
Current: CHF 125.46
Upside: -9.93%
Sanofi
Jul 6, 2026
Maintained: Hold
Price Target: €89.00 → €84.00
Current: €75.69
Upside: +10.98%
Roche Holding AG
Jun 30, 2026
Maintained: Hold
Price Target: CHF 346.00 → CHF 348.00
Current: CHF 353.60
Upside: -1.58%
Sartorius Stedim Biotech S.A.
Apr 23, 2026
Maintained: Buy
Price Target: €214.00
Current: €186.50
Upside: +14.75%
Merck KGaA
Apr 16, 2026
Maintained: Buy
Price Target: €153.00 → €147.00
Current: €135.10
Upside: +8.81%
Jan 15, 2026
Upgraded: Hold
Price Target: n/a
Current: $54.97
Upside: -
Sep 12, 2025
Downgraded: Sell
Price Target: $121 → $118
Current: $159.99
Upside: -26.25%
Jul 30, 2025
Maintained: Hold
Price Target: n/a
Current: $832.00
Upside: n/a
Jul 3, 2025
Maintained: Hold
Price Target: $65 → $60
Current: $44.24
Upside: n/a
May 30, 2024
Initiated Coverage: Buy
Price Target: 15,200p
Current: 12,042p
Upside: n/a
Oct 10, 2023
Maintained: Hold
Price Target: €13.00 → €10.50
Current: €0.85
Upside: n/a
Sep 25, 2023
Maintained: Buy
Price Target: €27.00 → €28.00
Current: €3.21
Upside: n/a
Sep 25, 2023
Maintained: Sell
Price Target: CHF 65.00 → CHF 64.00
Current: CHF 76.95
Upside: n/a
Sep 25, 2023
Maintained: Hold
Price Target: CHF 38.00 → CHF 21.00
Current: CHF 44.00
Upside: n/a
Sep 5, 2023
Maintained: Hold
Price Target: €38.00 → €36.00
Current: €24.42
Upside: n/a
Aug 8, 2023
Maintained: Buy
Price Target: $16 → $15
Current: $1.86
Upside: n/a
Jul 28, 2023
Maintained: Buy
Price Target: €410.00 → €545.00
Current: €869.40
Upside: n/a
May 12, 2023
Initiated Coverage: Sell
Price Target: kr 1,950 → kr 2,235
Current: kr 2,165
Upside: n/a
Jan 5, 2020
Downgraded: Hold
Price Target: $140 → $205
Current: $28.49
Upside: n/a
Jun 20, 2018
Upgraded: Buy
Price Target: n/a
Current: $33.60
Upside: n/a